Chief physician Chen Xin-yu′s experience in treatment of chronic liver disease based on the theory of qi and blood
ZHAO Xue-jun1,2 XIA Li2 LUO Ben-qing2 CHEN Xin-yu2▲
1.Graduate school,Hu′nan University of Traditional Chinese Medicine,Hu′nan Province,Changsha 410007,China;
2.Department of Hepatology,Chongqing Hospital of Traditional Chinese Medicine,Chongqing 400021,China
Abstract：Chief physician Chen Xin-yu is the third batch of academic heirs in the country,under the tutelage of the chief physician Luo Ben-qing,who is a famous and old traditional Chinese medicine (TCM) physician in Chongqing.Chen Xin-yu has engaged in hepatobiliary disease research for many years and has rich experience in clinical treatment of chronic liver disease.This paper summarizes her experience in the treatment of chronic hepatitis B complicated with non-alcoholic fatty liver disease.Chen Xin-yu considered that the pathological changes of the relationship between viscera,qi and blood,which penetrated the whole course of disease,and she summarized the basic pathogenesis of "disharmony of blood qi".She emphasized etiological treatment and focused on restoring the normal relationship between viscera,qi and blood in the clinical treatment.Based on this theory of qi and blood,she put forward to treat principle of "reconciling qi and blood,dispelling evil and relieving viscera".According to the severity of the disease,she takes medication in stages and levels.At the same time,she pays attention to protecting the vital qi and the function of the visceral function.
赵雪君；夏莉2；罗本清；陈新瑜. 陈新瑜主任从气血理论论治慢性肝病经验总结[J]. 中国当代医药, 2021, 28(5): 192-195.
ZHAO Xue-jun；XIA Li；LUO Ben-qing；CHEN Xin-yu. Chief physician Chen Xin-yu′s experience in treatment of chronic liver disease based on the theory of qi and blood. 中国当代医药, 2021, 28(5): 192-195.
Wang FS，Fan JG，Zhang Z，et al.The global burden of liver disease：the major impact of China[J].Hepatology，2014，60（6）：2099-2108.
[2]
Fan JG，Kim SU，Wong VW.New trends on obesity and NAFLD in Asia[J].J Hepatol，2017，67（4）：862-873.
[3]
Wang MM，Wang GS，Shen F，et al.Hepatic steatosis is highly prevalent in hepatitis B patients and negatively associated with virological factors[J].Dig Dis Sci，2014，59（10）：2571-2579.
Charatcharoenwitthaya P，Pongpaibul A，Kaosombatwattana U，et al.The prevalence of steatohepatitis in chronic hepatitis B patients and its impact on disease severity and treatment response[J].Liver Int，2017，37（4）：542-551.
[6]
Karacaer Z，Okur G，Cermik H，et al.Is there an influence of hepatic steatosis on fibrosis and necroinflammation in young patients with chronic viral hepatitis B?[J].Postgrad Med，2016，128（7）：697-700.
[7]
Seto WK，Hui RWH，Mak LY，et al.Association Between Hepatic Steatosis，Measured by Controlled Attenuation Parameter，and Fibrosis Burden in Chronic Hepatitis B[J].Clin Gastroenterol Hepatol，2018，16（4）：575-583.
京公网安备 11010502046607号